4th Quarter - Report
W STRATEGIES, LLC for ALEXION PHARMACEUTICALS
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
CMS IPPS rule as it relates to the NTAP program. H.R.133: Consolidated Appropriations Act, 2021. Administration Executive Order and Rulemaking in International Drug Pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.